Related Experiment Video
Updated: Sep 21, 2026
09:02
Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation
Published on: February 15, 2018
19.5K
Probiotics for Very-Low-Birth-Weight Neonates Are Less Effective in Practice Than Clinical Trials Suggest
The American Journal of Nursing
|August 24, 2023
Insights
Probiotics are increasingly used in U.S. neonatal units. While they lower necrotizing enterocolitis risk in premature infants, they do not reduce mortality or sepsis rates.
Area of Science:
- Neonatal Medicine
- Microbiology
- Clinical Research
Background:
- Necrotizing enterocolitis (NEC) is a significant cause of morbidity and mortality in premature infants.
- The gut microbiome plays a crucial role in infant health, and probiotics are explored as a way to modulate it.
- Probiotic use in neonatal intensive care units (NICUs) is growing.
Purpose of the Study:
- To evaluate the association between probiotic use in U.S. neonatal units and key infant health outcomes.
- To assess the impact of probiotics on necrotizing enterocolitis, mortality, and sepsis in very-low-birth-weight neonates.
Main Methods:
- Retrospective analysis of data from U.S. neonatal units.
- Comparison of outcomes between neonates who received probiotics and those who did not.
- Focus on very-low-birth-weight infants.
Main Results:
- A slow but steady increase in probiotic use was observed in U.S. neonatal units.
- Probiotic administration was associated with a reduced risk of necrotizing enterocolitis in very-low-birth-weight neonates.
- No significant association was found between probiotic use and lower rates of mortality or sepsis.
Conclusions:
- Probiotics may offer a protective effect against necrotizing enterocolitis in vulnerable premature infants.
- Current evidence does not support a benefit of probiotics in reducing mortality or sepsis in this population.
- Further research is needed to optimize probiotic strategies in neonatal care.
Abstract:
According to this study: The use of probiotics in U.S. neonatal units is increasing slowly and is associated with a lower risk of necrotizing enterocolitis in very-low-birth-weight neonates but not with a lower risk of mortality or sepsis.
Related Concept Videos
01:30Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
01:28Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
01:21Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...